Decision Investments’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Other funds holding HQL
PCM
NIM
FHA
AAM
1WA
Decision Investments's HQL Position: Q2 2026 in Review
Decision Investments reduced its abrdn Life Sciences Investors (HQL) stake by 2.5% in Q2 2026, selling an estimated $7.95K and leaving 17,254 shares worth $345K. The position accounts for 0.31% of the portfolio, ranked #58.
Decision Investments first reported a position in HQL in Q4 2025 and has held it in 3 quarters since. 83 funds tracked by Wall St. Rank hold HQL as of Q2 2026.
- Decision Investments held 17,254 shares of abrdn Life Sciences Investors worth $345K as of Q2 2026.
- Decision Investments sold 450 abrdn Life Sciences Investors shares in Q2 2026, an estimated $7.95K.
- abrdn Life Sciences Investors made up 0.31% of Decision Investments's portfolio in Q2 2026, its #58 holding.
- Decision Investments first reported a position in abrdn Life Sciences Investors in Q4 2025 and has held it in 3 quarters since.
- 83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.
Based on Decision Investments's 13F filing for Q2 2026, filed 13 Jul 2026.